Design, synthesis and biological evaluation of a bivalent μ opiate and adenosine A1 receptor antagonist

Design, synthesis and biological evaluation of a bivalent μ opiate and adenosine A1 receptor antagonist Hybrid bivalent ligands with opiate and enkephalin pharmacophores Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors Synthesis and Preliminary In vitro Investigation of Bivalent Ligands Containing Homo- and Heterodimeric Pharmacophores at μ, δ, and κ Opioid Receptors Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors 14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies Design, Synthesis, and Biological Evaluation of Novel Bifunctional C-Terminal-Modified Peptides for δ/μ Opioid Receptor Agonists and Neurokinin-1 Receptor Antagonists Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors Design and synthesis of selective α1B adrenoceptor antagonists Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK₂) Receptors by Novel Bivalent Ligands